Literature DB >> 8798590

Structure/function analysis of the amino-terminal region of the 1 and 2 subunits of Na,K-ATPase.

S E Daly1, L K Lane, R Blostein.   

Abstract

The alpha2 isoform of the Na,K-ATPase exhibits kinetic behavior distinct from that of the alpha1 isoform. The distinctive behavior is apparent when the reaction is carried out under conditions (micromolar ATP concentration) in which the K+ deocclusion pathway of the reaction cycle is rate-limiting; the alpha1 activity is inhibited by K+, whereas alpha2 is stimulated. When 32 NH2-terminal amino acid residues are removed from alpha1, the kinetic behavior of the mutant enzyme (alpha1M32) is similar to that of alpha2 (Daly, S. E., Lane, L. K., and Blostein, R. (1994) J. Biol. Chem. 269, 23944-23948). In the current study, the region of the alpha1 NH2 terminus involved in modulating this kinetic behavior has been localized to the highly charged sequence comprising residues 24-32. Within this nonapeptide, differences between alpha1 and alpha2 are conservative and are confined to residues 25-27. The behavior of two chimeric enzymes: (i) alpha1 with the first 32 residues identical to the alpha2 sequence, alpha1 (1-32alpha2), and (ii) alpha2 with the first 32 residues identical to the alpha1 sequence, alpha2(1-32alpha1), indicates that the distinctive kinetic behavior of alpha1 and alpha2 is not due to the 24-32 NH2-terminal domain, per se, but rather to its interaction with other, isoform-specific region(s) of the alpha1 protein. We also demonstrate that the distinct K+ activation profiles of either alpha2 or alpha1M32, compared to alpha1 is due to a faster release of K+ from the K+-occluded enzyme, and to a higher affinity for ATP. This was determined in studies using two approaches: (i) kinetic analysis of the reaction modeled according to a branched pathway of K+ deocclusion through low and high affinity ATP pathways and, (ii) measurements of the (rapid) phosphorylation of the enzyme (E1 conformation) by [gamma-32P]ATP following the rate-limiting formation of the K+-free enzyme from the K+-occluded state (E2(K) --> E1 + K+). The observed kinetic differences between alpha2 and alpha1 suggest that these Na,K-ATPase isoforms differ in the steady-state distribution of E1 and E2 conformational states.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798590     DOI: 10.1074/jbc.271.39.23683

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Curcumin modulation of Na,K-ATPase: phosphoenzyme accumulation, decreased K+ occlusion, and inhibition of hydrolytic activity.

Authors:  Yasser A Mahmmoud
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

2.  Alterations in the alpha2 isoform of Na,K-ATPase associated with familial hemiplegic migraine type 2.

Authors:  Laura Segall; Alessandra Mezzetti; Rosemarie Scanzano; J Jay Gargus; Enrico Purisima; Rhoda Blostein
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-21       Impact factor: 11.205

3.  Epitope and mimotope for an antibody to the Na, K-ATPase.

Authors:  T Pacholczyk; K J Sweadner
Journal:  Protein Sci       Date:  1997-07       Impact factor: 6.725

4.  Cholesterol depletion inhibits Na+,K+-ATPase activity in a near-native membrane environment.

Authors:  Alvaro Garcia; Bogdan Lev; Khondker R Hossain; Amy Gorman; Dil Diaz; Thi Hanh Nguyen Pham; Flemming Cornelius; Toby W Allen; Ronald J Clarke
Journal:  J Biol Chem       Date:  2019-02-15       Impact factor: 5.157

5.  Evolutionary Analysis of the Lysine-Rich N-terminal Cytoplasmic Domains of the Gastric H+,K+-ATPase and the Na+,K+-ATPase.

Authors:  Dil Diaz; Ronald J Clarke
Journal:  J Membr Biol       Date:  2018-07-28       Impact factor: 1.843

Review 6.  Role of conserved TGDGVND-loop in Mg2+ binding, phosphorylation, and energy transfer in Na,K-ATPase.

Authors:  P L Jorgensen; J R Jorgensen; P A Pedersen
Journal:  J Bioenerg Biomembr       Date:  2001-10       Impact factor: 2.945

Review 7.  Menkes copper-translocating P-type ATPase (ATP7A): biochemical and cell biology properties, and role in Menkes disease.

Authors:  Ilia Voskoboinik; James Camakaris
Journal:  J Bioenerg Biomembr       Date:  2002-10       Impact factor: 2.945

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.